Abstract
Background: High-resolution positron-emission mammography (PEM) is a new device, which allows the imaging of breast tissue. A prospective study was performed to assess the accuracy of PEM in newly diagnosed breast cancer patients. Methods: In a prospective multicenter study, 44 women with confirmed breast cancers were imaged with a high-resolution PEM scanner (Naviscan PET Systems, Rockville, MD) with 18F-fluorodeoxyglucose. The images were blindly evaluated and were compared with final pathology. Results: The majority of the index lesions were seen on PEM (89%, 39/44). PEM detected 4 of 5 incidental breast cancers, 3 of which were not seen by any other imaging modalities. Of 19 patients undergoing breast-conserving surgery, PEM correctly predicted 6 of 8 (75%) patients with positive margins and 100% (11/11) with negative margins. Conclusion: The current PEM device shows promise in detecting breast malignancies and may assist in the planning of adequate partial mastectomy procedures to better ensure negative margins.
| Original language | English |
|---|---|
| Pages (from-to) | 628-632 |
| Number of pages | 5 |
| Journal | American Journal of Surgery |
| Volume | 190 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 2005 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adult
- Aged
- Aged, 80 and over
- Breast Neoplasms/diagnostic imaging
- Female
- Fluorodeoxyglucose F18
- Humans
- Mammography/methods
- Middle Aged
- Pilot Projects
- Positron-Emission Tomography/methods
- Predictive Value of Tests
- Prospective Studies
- Radiopharmaceuticals
- Single-Blind Method
Fingerprint
Dive into the research topics of 'Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver